Root Financial Partners
EDIT icon

Root Financial Partners’s Editas Medicine EDIT Stock Holding History

Root Financial Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$267 Buy
+104
New +$305 ﹤0.01% 3434
2026
Q2 		– Sell
-503
Closed -$1.24K – 1197
2026
Q1 		$1.24K Buy
+503
New +$1.06K ﹤0.01% 2519
2025
Q4 		– Sell
-100
Closed -$347 – 2459
2025
Q3 		$347 Buy
+100
New +$279 ﹤0.01% 2172

Other funds holding EDIT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Root Financial Partners's EDIT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Editas Medicine (EDIT) in Q3 2026: 104 shares worth $267. The stake represents ﹤0.01% of the portfolio and ranks #3434 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in EDIT as recently as Q1 2026.

Root Financial Partners first reported a position in EDIT in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.24K in Q1 2026. 162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Root Financial Partners held 104 shares of Editas Medicine worth $267 as of Q3 2026.
  • Editas Medicine was a new Root Financial Partners position in Q3 2026.
  • Editas Medicine made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3434 holding.
  • Root Financial Partners first reported a position in Editas Medicine in Q3 2025 and has held it in 3 quarters since.
  • Root Financial Partners's Editas Medicine position peaked at $1.24K in Q1 2026.
  • 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.